MetaCap

Doximity Quarterly Income Statement

NYSE: DOCSTechnologyEDP ServicesUSD

30.50+1.12 (+3.81%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Doximity revenue and earnings

In the quarter ended Jun 30, 2026, Doximity generated $156.6 million in revenue, up 7.3% from the same quarter a year earlier. Net income was $24.3 million (-54.4% year over year), for a net margin of 15.5% versus a median of 36.5% in the prior 5 quarters. Gross margin was 84.9% (down from 89.2%) and operating margin 21.5%.

Diluted earnings per share came in at $0.13, down from $0.27.

Summary generated from market data by MetaCap's automated system. Methodology

Doximity income statement (quarterly)

Doximity quarterly income statement
Quarter (USD)Q1 20272026-06-30Q4 20262026-03-31Q3 20262025-12-31Q2 20262025-09-30Q1 20262025-06-30Q4 20252025-03-31Q3 20252024-12-31Q2 20252024-09-30Q1 20252024-06-30Q4 20242024-03-31Q3 20242023-12-31Q2 20242023-09-30
Revenue156.62M145.37M185.05M168.53M145.91M138.29M168.60M136.83M126.68M118.06M135.28M113.61M
Revenue growth (YoY)+7.34%+5.12%+9.76%+23.16%+15.19%+17.14%+24.63%+20.44%+16.79%+6.39%+17.37%+11.18%
Cost of Revenue23.69M19.41M18.70M16.43M15.79M14.47M14.18M13.68M13.55M12.57M12.19M12.76M
Gross Profit132.93M125.97M166.35M152.10M130.12M123.82M154.42M123.16M113.13M105.49M123.09M100.85M
Operating Expenses99.28M101.14M94.46M88.42M75.60M75.14M74.50M70.01M67.07M63.64M64.54M67.06M
Research & Development38.48M39.11M34.59M30.20M26.80M24.80M22.42M23.24M22.57M20.15M19.95M19.96M
Selling, General & Admin60.80M62.03M59.86M58.22M48.80M50.34M52.08M44.47M44.50M43.49M44.60M39.17M
Operating Income33.64M24.83M71.90M63.68M54.52M48.68M79.92M53.14M46.05M41.85M58.55M33.79M
Other Income (Expense)6.72M7.29M8.90M9.26M9.63M9.71M9.91M9.03M7.12M6.10M4.48M5.90M
Pretax Income40.36M32.12M80.80M72.94M64.15M58.39M89.84M62.17M53.17M47.95M63.03M39.70M
Income Tax16.05M13.01M19.24M10.88M10.83M-4.06M14.64M18.02M11.79M7.33M15.08M9.09M
Net Income24.32M19.11M61.56M62.06M53.32M62.46M75.20M44.15M41.38M40.62M47.96M30.60M
Net Income growth (YoY)-54.40%-69.40%-18.14%+40.55%+28.86%+53.77%+56.80%+44.28%+45.66%+32.44%+43.29%+16.36%
EPS (Basic)0.130.110.330.330.280.330.400.240.220.210.260.16
EPS (Diluted)0.130.090.310.310.270.310.370.220.210.200.240.15
Shares Outstanding (Basic)182.57M—187.48M187.71M187.98M—187.16M186.25M185.61M—186.31M193.11M
Shares Outstanding (Diluted)191.17M—199.22M200.75M201.16M—202.23M200.41M199.22M—200.46M209.01M
EBITDA37.93M28.96M75.89M67.15M57.31M51.51M82.58M55.76M48.62M44.40M61.06M36.40M
Gross Margin84.87%86.65%89.89%90.25%89.18%89.54%91.59%90.01%89.30%89.36%90.99%88.77%
Operating Margin21.48%17.08%38.85%37.79%37.36%35.20%47.40%38.84%36.35%35.45%43.28%29.74%
Net Margin15.53%13.15%33.27%36.82%36.54%45.17%44.60%32.27%32.66%34.41%35.45%26.94%

This table shows 12 quarterly periods of Doximity's income statement, from Q1 2027 back to Q2 2024, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow DOCS's reporting calendar. What is a income statement?

More financial data